IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis
- PMID: 10840462
IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis
Abstract
Purpose: Chronic Prostatitis, or Chronic Pelvic Pain Syndrome [CPPS], is a common disorder characterized by pelvic pain and varying degrees of inflammation in expressed prostatic secretions (EPS). In search of markers to more clearly define CPPS, we compared proinflammatory cytokines interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) levels in EPS from men with CPPS, to healthy men and men with Benign Prostatic Hyperplasia (BPH).
Methods: 78 men: controls (n = 16), BPH (n = 14), CPPS IIIA [>/=10 white blood cells per high power field (WBC/hpf) in EPS] (n = 18), CPPS IIIB [<10 WBC/hpf in EPS] (n = 20), and asymptomatic inflammatory prostatitis (AIP) (n = 10) were evaluated for EPS WBC, and IL-1beta and TNF-alpha by ELISA.
Results: IL-1beta and TNF-alpha levels in EPS were usually detectable in men with CPPS IIIA (89% and 45%, respectively) or AIP (90%; 100%), but less often in controls (31%; 17%), BPH (57%; 15%), and CPPS IIIB (35%; 15%) respectively. IL-1beta and TNF-alpha levels were higher in CPPS IIIA versus CPPS IIIB, and in AIP versus controls or BPH (p's <0.001). Cut-points for IL-1beta and TNF-alpha discriminated AIP from controls (predictive values = 94% and 83%, respectively) and CPPS IIIA from CPPS IIIB (predictive values 84% and 100%). Overall, there was a correlation between IL-1beta and TNF-alpha (p <0.003), but no correlation between WBC and IL-1beta (p <0.1) or TNF-alpha (p <0.50).
Conclusions: Cytokines are frequently present and elevated in the EPS from men with CPPS IIIA and AIP and provide a novel means for identification, characterization and potential management of men with CPPS that differs from traditional methods based on WBC.
Similar articles
-
Heat-shock protein 70 expression in the seminal plasma of patients with chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome.Prostate Cancer Prostatic Dis. 2010 Dec;13(4):338-42. doi: 10.1038/pcan.2010.22. Epub 2010 Jun 29. Prostate Cancer Prostatic Dis. 2010. PMID: 20585345
-
Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.Eur Urol. 2007 Feb;51(2):524-33; discussion 533. doi: 10.1016/j.eururo.2006.07.016. Epub 2006 Jul 28. Eur Urol. 2007. PMID: 16905241
-
Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls.J Urol. 2003 Sep;170(3):818-22. doi: 10.1097/01.ju.0000082252.49374.e9. J Urol. 2003. PMID: 12913707
-
Acute and chronic prostatitis.Med Clin North Am. 2004 Mar;88(2):483-94. doi: 10.1016/S0025-7125(03)00169-X. Med Clin North Am. 2004. PMID: 15049589 Review.
-
Chronic pelvic pains represent the most prominent urogenital symptoms of "chronic prostatitis".Urology. 1996 Nov;48(5):715-21; discussion 721-2. doi: 10.1016/S0090-4295(96)00421-9. Urology. 1996. PMID: 8911515 Review.
Cited by
-
Influence of Experimental Autoimmune Prostatitis on Sexual Function and the Anti-inflammatory Efficacy of Celecoxib in a Rat Model.Front Immunol. 2020 Sep 9;11:574212. doi: 10.3389/fimmu.2020.574212. eCollection 2020. Front Immunol. 2020. PMID: 33013933 Free PMC article.
-
Theories of prostatitis etiology.Curr Urol Rep. 2002 Aug;3(4):307-12. doi: 10.1007/s11934-002-0055-y. Curr Urol Rep. 2002. PMID: 12149162 Review.
-
Effect and Mechanism of Aloin in Ameliorating Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Network Pharmacology and Experimental Verification.Drug Des Devel Ther. 2025 Mar 14;19:1945-1969. doi: 10.2147/DDDT.S473678. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40110504 Free PMC article.
-
Male Lower Urinary Tract Dysfunction: An Underrepresented Endpoint in Toxicology Research.Toxics. 2022 Feb 16;10(2):89. doi: 10.3390/toxics10020089. Toxics. 2022. PMID: 35202275 Free PMC article. Review.
-
Fabrication and application of targeted ciprofloxacin nanocarriers for the treatment of chronic bacterial prostatitis.Int J Pharm X. 2024 Apr 18;7:100247. doi: 10.1016/j.ijpx.2024.100247. eCollection 2024 Jun. Int J Pharm X. 2024. PMID: 38706465 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous